Tumor versus stromal cells in culture - Survival of the fittest?

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Talasila, Krishna M ^a   Brekka, Narve ^a   Mangseth, Kjersti ^b   Stieber, Daniel ^c   Evensen, Lasse ^a   Rosland, Gro V ^a   Torsvik, Anja ^a   Wagner, Marek ^a   Niclou, Simone P ^c   Mahesparan, Rupavathana ^b   Vintermyr, Olav K ^b   Bjerkvig, Rolf ^a,c   Nigro, Janice M ^a   Miletic, Hrvoje ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ISOCITRATE DEHYDROGENASE; NESTIN; SMOOTH MUSCLE ACTIN; TRANSCRIPTION FACTOR SOX2;

ADHERENT CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOMA; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; EGFR GENE; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; GENE MUTATION; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IDH GENE; MALE; MONOLAYER CULTURE; NEURAL STEM CELL; NONHUMAN; OLIGODENDROGLIOMA; RAT; STROMA CELL; SUSPENSION CELL CULTURE; TUMOR CELL; TUMOR XENOGRAFT;

ANIMALS; BRAIN NEOPLASMS; GLIOBLASTOMA; HUMANS; MUTATION; OLIGODENDROGLIOMA; RATS; RECEPTOR, EPIDERMAL GROWTH FACTOR; STROMAL CELLS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 84891456813     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0081183     Document Type: Article

References (43)

1. Schulte A, Gunther HS, Martens T, Zapf S, Riethdorf S, et al. (2012) Glioblastoma stem-like cell lines with either maintenance or loss of high-level EGFR amplification, generated via modulation of ligand concentration. Clin Cancer Res 18: 1901-1913.
2. Pandita A, Aldape KD, Zadeh G, Guha A, James CD (2004) Contrasting in vivo and in vitro fates of glioblastoma cell subpopulations with amplified EGFR. Genes Chromosomes Cancer 39: 29-36. (Pubitemid 37475250)
3. Bigner SH, Humphrey PA, Wong AJ, Vogelstein B, Mark J, et al. (1990) Characterization of the epidermal growth factor receptor in human glioma cell lines and xenografts. Cancer Res 50: 8017-8022.
4. Talasila KM, Soentgerath A, Euskirchen P, Rosland GV, Wang J, et al. (2013) EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis. Acta Neuropathol.
5. Piaskowski S, Bienkowski M, Stoczynska-Fidelus E, Stawski R, Sieruta M, et al. (2011) Glioma cells showing IDH1 mutation cannot be propagated in standard cell culture conditions. Br J Cancer 104: 968-970.
6. Branle F, Lefranc F, Camby I, Jeuken J, Geurts-Moespot A, et al. (2002) Evaluation of the efficiency of chemotherapy in in vivo orthotopic models of human glioma cells with and without 1p19q deletions and in C6 rat orthotopic allografts serving for the evaluation of surgery combined with chemotherapy. Cancer 95: 641-655. (Pubitemid 34810191)
7. Klink B, Miletic H, Stieber D, Huszthy PC, Valenzuela JA, et al. (2013) A Novel, Diffusely Infiltrative Xenograft Model of Human Anaplastic Oligodendroglioma with Mutations in FUBP1, CIC, and IDH1. PLoS One 8: e59773.
8. Claes A, Schuuring J, Boots-Sprenger S, Hendriks-Cornelissen S, Dekkers M, et al. (2008) Phenotypic and genotypic characterization of orthotopic human glioma models and its relevance for the study of anti-glioma therapy. Brain Pathol 18: 423-433. (Pubitemid 351782851)
9. Kelly JJ, Blough MD, Stechishin OD, Chan JA, Beauchamp D, et al. (2010) Oligodendroglioma cell lines containing t(1;19)(q10;p10). Neuro Oncol 12: 745-755.
10. Bjerkvig R, Tonnesen A, Laerum OD, Backlund EO (1990) Multicellular tumor spheroids from human gliomas maintained in organ culture. J Neurosurg 72: 463-475. (Pubitemid 20072971)
11. Evensen L, Micklem DR, Blois A, Berge SV, Aarsaether N, et al. (2009) Mural cell associated VEGF is required for organotypic vessel formation. PLoS One 4: e5798.
12. Huszthy PC, Giroglou T, Tsinkalovsky O, Euskirchen P, Skaftnesmo KO, et al. (2009) Remission of invasive, cancer stem-like glioblastoma xenografts using lentiviral vector-mediated suicide gene therapy. PLoS One 4: e6314.
13. Sakariassen PO, Prestegarden L, Wang J, Skaftnesmo KO, Mahesparan R, et al. (2006) Angiogenesis-independent tumor growth mediated by stem-like cancer cells. Proc Natl Acad Sci U S A 103: 16466-16471. (Pubitemid 44715219)
14. Wang J, Daphu I, Pedersen PH, Miletic H, Hovland R, et al. (2011) A novel brain metastases model developed in immunodeficient rats closely mimics the growth of metastatic brain tumours in patients. Neuropathol Appl Neurobiol 37: 189-205.
15. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, et al. (2006) Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9: 391-403. (Pubitemid 43668737)
16. Glass R, Synowitz M, Kronenberg G, Walzlein JH, Markovic DS, et al. (2005) Glioblastoma-induced attraction of endogenous neural precursor cells is associated with improved survival. J Neurosci 25: 2637-2646. (Pubitemid 40365175)
17. Mazzoleni S, Politi LS, Pala M, Cominelli M, Franzin A, et al. (2010) Epidermal growth factor receptor expression identifies functionally and molecularly distinct tumor-initiating cells in human glioblastoma multiforme and is required for gliomagenesis. Cancer Res 70: 7500-7513.
18. Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, et al. (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360: 765-773.
19. Morozov A, Downey RJ, Healey J, Moreira AL, Lou E, et al. (2009) Benign mesenchymal stromal cells in human sarcomas. Clin Cancer Res 16: 5630-5640.
20. McLean K, Gong Y, Choi Y, Deng N, Yang K, et al. (2011) Human ovarian carcinoma-associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production. J Clin Invest 121: 3206-3219.
21. Alliot F, Rutin J, Leenen PJ, Pessac B (1999) Pericytes and periendothelial cells of brain parenchyma vessels co-express aminopeptidase N, aminopeptidase A, and nestin. J Neurosci Res 58: 367-378. (Pubitemid 29508570)
22. Calatozzolo C, Maderna E, Pollo B, Gelati M, Marras C, et al. (2006) Prognostic value of CXCL12 expression in 40 low-grade oligodendrogliomas and oligoastrocytomas. Cancer Biol Ther 5: 827-832. (Pubitemid 44775142)
23. Dahlstrand J, Collins VP, Lendahl U (1992) Expression of the class VI intermediate filament nestin in human central nervous system tumors. Cancer Res 52: 5334-5341.
24. Chamberlain G, Fox J, Ashton B, Middleton J (2007) Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25: 2739-2749. (Pubitemid 350127858)
25. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, et al. (2008) A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3: 301-313.
26. Kim SM, Kang SG, Park NR, Mok HS, Huh YM, et al. (2011) Presence of glioma stroma mesenchymal stem cells in a murine orthotopic glioma model. Childs Nerv Syst 27: 911-922.
27. Dudley AC, Khan ZA, Shih SC, Kang SY, Zwaans BM, et al. (2008) Calcification of multipotent prostate tumor endothelium. Cancer Cell 14: 201-211.
28. Ernst A, Hofmann S, Ahmadi R, Becker N, Korshunov A, et al. (2009) Genomic and expression profiling of glioblastoma stem cell-like spheroid cultures identifies novel tumor-relevant genes associated with survival. Clin Cancer Res 15: 6541-6550.
29. de Ridder LI, Laerum OD, Mork SJ, Bigner DD (1987) Invasiveness of human glioma cell lines in vitro: relation to tumorigenicity in athymic mice. Acta Neuropathol 72: 207-213. (Pubitemid 17006839)
30. Maunoury R (1977) Establishment and characterization of 5 human cell lines derived from a series of 50 primary intracranial tumors. Acta Neuropathol 39: 33-41. (Pubitemid 8128372)
31. Bigner SH, Bullard DE, Pegram CN, Wikstrand CJ, Bigner DD (1981) Relationship of in vitro morphologic and growth characteristics of established human glioma-derived cell lines to their tumorigenicity in athymic nude mice. J Neuropathol Exp Neurol 40: 390-409. (Pubitemid 12251823)
32. Thomas C, Ely G, James CD, Jenkins R, Kastan M, et al. (2001) Glioblastomarelated gene mutations and over-expression of functional epidermal growth factor receptors in SKMG-3 glioma cells. Acta Neuropathol 101: 605-615. (Pubitemid 32684760)
33. Eshleman JS, Carlson BL, Mladek AC, Kastner BD, Shide KL, et al. (2002) Inhibition of the mammalian target of rapamycin sensitizes U87 xenografts to fractionated radiation therapy. Cancer Res 62: 7291-7297. (Pubitemid 36025252)
34. Thomas CY, Chouinard M, Cox M, Parsons S, Stallings-Mann M, et al. (2003) Spontaneous activation and signaling by overexpressed epidermal growth factor receptors in glioblastoma cells. Int J Cancer 104: 19-27. (Pubitemid 36184143)
35. Fael Al-Mayhani TM, Ball SL, Zhao JW, Fawcett J, Ichimura K, et al. (2009) An efficient method for derivation and propagation of glioblastoma cell lines that conserves the molecular profile of their original tumours. J Neurosci Methods 176: 192-199.
36. Pollard SM, Yoshikawa K, Clarke ID, Danovi D, Stricker S, et al. (2009) Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell 4: 568-580.
37. Kelly JJ, Stechishin O, Chojnacki A, Lun X, Sun B, et al. (2009) Proliferation of human glioblastoma stem cells occurs independently of exogenous mitogens. Stem Cells 27: 1722-1733.
38. Najbauer J, Huszthy PC, Barish ME, Garcia E, Metz MZ, et al. (2012) Cellular host responses to gliomas. PLoS One 7: e35150.
39. Golebiewska A, Bougnaud S, Stieber D, Brons NH, Vallar L, et al. (2013) Side population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cells. Brain 136: 1462-1475.
40. Louis D, Ohgaki H, Wiestler O, Cavenee W (2007) WHO Classification of Tumours of the Central Nervous System; Bosman F, Jaffe E, Lakhani S, Ohgaki H, editors. Lyon: IARC.
41. Martin F, Lemmen LJ (1952) Calcification in intracranial neoplasms. Am J Pathol 28: 1107-1131.
42. Tsai RY, McKay RD (2000) Cell contact regulates fate choice by cortical stem cells. J Neurosci 20: 3725-3735. (Pubitemid 30266235)
43. Rajan P, Panchision DM, Newell LF, McKay RD (2003) BMPs signal alternately through a SMAD or FRAP-STAT pathway to regulate fate choice in CNS stem cells. J Cell Biol 161: 911-921. (Pubitemid 36718424)